Reversal of heparin after cardiac surgery: Protamine titration using a statistical model

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 29, Issue 3, 2015, Pages 710-714

  Ödling Davidsson, Fredrik ^a   Johagen, Daniel ^a   Appelblad, Micael ^a   Svenmarker, Staffan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

cardiac surgery; cardiopulmonary bypass; heparin; point of care testing; protamine; statistical modeling

Indexed keywords

HEPARIN; PROTAMINE; HEPARIN ANTAGONIST;

AGED; ARTICLE; BLOOD CLOTTING TIME; BODY SURFACE; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG CLEARANCE; DRUG DOSE TITRATION; ELECTIVE SURGERY; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATING ROOM; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL MODEL; SURGICAL PATIENT; THROMBOCYTE COUNT; UNIVERSITY HOSPITAL; ADVERSE EFFECTS; BLOOD; MIDDLE AGED; POINT OF CARE SYSTEM; TRENDS;

AGED; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; PROTAMINES;

EID: 84930082457     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2014.12.006     Document Type: Article

References (16)

1. M.S. Avidan, E.L. Alcock, and J. Da Fonseca Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery Br J Anaesth 92 2004 178 186
2. K.A. Aziz, O. Masood, and J.A. Hoschtitzky Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 5 2006 469 482
3. G.J. Despotis, J.H. Joist, and L.T. Goodnough Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements J Thorac Cardiovasc Surg 113 1997 611 613
4. T. Miyashita, T. Nakajima, and Y. Hayashi Hemostatic effects of low-dose protamine following cardiopulmonary bypass Am J Hematol 64 2000 112 115
5. A.B. Vonk, D. Veerhoek, and C.E. van den Brom Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery J Cardiothorac Vasc Anesth 28 2014 235 241
6. S. Svenmarker, S. Häggmark, and M. Hultin Static blood-flow control during cardiopulmonary bypass is a compromise of oxygen delivery Eur J Cardiothorac Surg 37 2010 218 222
7. J. Suárez Cuenca, P. Gayoso Diz, and F. Gude Sampedro Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgery J Extra Corpor Technol 45 2013 235 241
8. S.B. Nadler, J.H. Hidalgo, and T. Bloch Prediction of blood volume in normal human adults Surgery 51 1962 224 232
9. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
10. M. Codispoti, and P.S. Mankad Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: A review of current UK practice Perfusion 15 2000 191 201
11. F. Gerbode, R. Hurt, and J.J. Osborn The neutralization of heparin by protamine in extracorporeal circulation J Thorac Surg 32 1956 612 619
12. E. Ortmann, A.A. Klein, and L.D. Sharples Point-of-care assessment of hypothermia and protamine-induced platelet dysfunction with multiple electrode aggregometry (Multiplate®) in patients undergoing cardiopulmonary bypass Anesth Analg 116 2013 533 540
13. R. Gertler, G. Wiesner, and P. Tassani-Prell Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine? J Cardiothorac Vasc Anesth 25 2011 981 986
14. T. Ammar, C.F. Fisher, and K. Sarier The effects of thrombocytopenia on the activated coagulation time Anesth Analg 83 1996 1185 1188
15. B.S. Bull, W.M. Huse, and F.S. Brauer Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage J Thorac Cardiovasc Surg 69 1975 685 689
16. J. Ichikawa, M. Kodaka, and K. Nishiyama Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery J Cardiothorac Vasc Anesth 28 2014 1015 1019